About DeepMirror

DeepMirror’s goal is to enable every biopharma team to discover better medications more quickly by making AI-powered drug creation as easy as using a spreadsheet. In the end, improving everyone’s health and propelling the biological century forward. AI can now double the speed of preclinical drug discovery. But due to trust and ability gaps, less than 10% of biopharma teams have embraced AI. Everyone can use DeepMirror’s platform, which enables teams to install AI in minutes and provides a seamless user experience. This empowers enterprises as they move from discovery to clinic. Since its founding in 2019, universities, biotech companies, and pharmaceutical companies all across the world have been using DeepMirror.